2010-11-11 00:00:00,Abbott Laboratories Reaffirms FY 2010 EPS Call
2011-01-04 00:00:00,India Patent Office Rejects Abbott HIV Drug
2011-01-10 00:00:00,Abbott Laboratories Receives CE Mark Approval For First Drug Eluting Bioresorbable Vascular Scaffold For Treatment Of Coronary Artery Disease
2011-01-20 00:00:00,Abbott XIENCE PRIME Receives CE Mark For Treatment Of Most Advanced Form Of Arterial Disease
2011-01-26 00:00:00,Abbott Laboratories Announces Restructuring In Its Pharmaceutical Issues FY 2011 EPS Guidance In Line With Estimates
2011-01-31 00:00:00,Abbott Laboratories Receives Regulatory Clearance In United States
2011-02-24 00:00:00,Abbott Boston Scientific Corporations Boston Scientific Ceska Johnson Medtronic Czechia and Others Win Daily News
2011-03-30 00:00:00,Abbott Laboratories Announces Disease Trial To Explore Benefit Of New Therapeutic Monitoring Parameters For Patients
2011-04-04 00:00:00,Data From Clinical Trial of Abbott MitraClip System Demonstrate Durable Clinical Benefits for Patients With Mitral Regurgitation Two Years After Treatment
2011-04-20 00:00:00,Abbott Laboratories Reaffirms FY 2011 EPS Guidance
2011-06-02 00:00:00,Abbott Laboratories In Talks To Settle US Probe Of Depakote
2011-06-14 00:00:00,Abbott Laboratories Receives FDA Approval For CREON Dosage For Patients With Exocrine Pancreatic Insufficiency Due To Cystic Fibrosis
2011-07-20 00:00:00,Abbott Laboratories Raises FY 2011 EPS Guidance
2011-07-29 00:00:00,Perdue Kidd Vickery Files Lawsuit Against Abbott Laboratories For Inadequate Leukemia And Cancer Warning
2011-08-09 00:00:00,Biogen Idec Inc And Abbott Laboratories Announce Positive Results From First Registrational Trial For Daclizumab HYP In Multiple Sclerosis
2011-08-10 00:00:00,Abbott Laboratories Receives FDA Approval For RX Herculink Elite Renal Stent System For Treatment of Renal Artery Disease
2011-09-08 00:00:00,Abbott Laboratories Initiates International ABSORB BTK Clinical Trial For Treatment Of Critical Limb Ischemia
2011-10-19 00:00:00,Abbott Laboratories To Separate Into Two Companies In Diversified Medical Products And Pharmaceuticals
2011-10-20 00:00:00,plc Launches Assay on Abbot ARCHITECT Platform
2011-11-30 00:00:00,Law Offices of Howard Smith Announces Investigation of Abbott Laboratories
2011-12-22 00:00:00,Abbott Laboratories Initiates Clinical Trial To Study Drug Eluting Bioresorbable Therapy For Treatment of Peripheral Artery Disease
2012-01-18 00:00:00,Abbott STARLIMS LIMS Technology to be Installed in FDA Testing Laboratories
2012-01-25 00:00:00,Abbott Laboratories Issues FY 2012 Guidance In Line With Call
2012-01-30 00:00:00,DNDi And Abbott Laboratories Expand Partnership To Boost Innovation for Neglected Tropical Diseases
2012-02-29 00:00:00,Abbott Laboratories And Galapagos NV Announce Global Collaboration For Oral In Phase II To Treat Autoimmune Diseases
2012-03-06 00:00:00,Abbott Laboratories And Merck Collaborate To Develop Companion Diagnostic Test For Investigational Cancer Therapy
2012-03-07 00:00:00,Abbott Absolute Pro Vascular Stent System Receives FDA Approval For Treatment Of Iliac Artery Disease
2012-03-30 00:00:00,Abbott Molecular System And Tests For Broad Microbial Identification Obtain CE Marking
2012-04-18 00:00:00,Abbott Laboratories Raises FY 2012 EPS Guidance
2012-04-19 00:00:00,Abbott Laboratories Presents Positive Results From Phase II Study For Treatment Of Hepatitis C
2012-04-20 00:00:00,Abbott Laboratories Receives FDA Clearance To Use iFS Advanced Femtosecond Laser Technology For Arcuate Incisions In Cataract Surgery
2012-05-03 00:00:00,Abbott Laboratories Announces Collaboration With Biocon Syngene To Open First Nutrition Center In India
2012-06-05 00:00:00,Abbott Laboratories In Cooperation With Neurocrine Announces Initiation Of Phase 3 Study Of Elagolix In Patients With Endometriosis
2012-09-06 00:00:00,Abbott Laboratories To Collaborate With Astellas In CMV Vaccine Trial
2012-09-13 00:00:00,Abbott Laboratories Declares Quarterly Dividend
2012-10-02 00:00:00,Judge Accepts Abbott Laboratories Misbranding
2012-10-15 00:00:00,Abbott Laboratories Oral Hepatitis C Regimen Cure Rate
2012-10-17 00:00:00,Abbott Laboratories Narrows FY 2012 EPS Guidance
2012-10-18 00:00:00,Abbott Laboratories Shares Scorched By Kidney Drug
2012-10-19 00:00:00,Pipeline Setback at Abbott Analyst Blog
2012-10-22 00:00:00,Abbott Laboratories Company Could Unlock Value For Shareholders
